erythromycin has been researched along with pentobarbital in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bartosek, I; Casacci, F; Corti, F; De Marchi, F; Guaitani, A; Pacei, E; Villa, P | 1 |
Landon, MJ | 1 |
1 review(s) available for erythromycin and pentobarbital
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for erythromycin and pentobarbital
Article | Year |
---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effects of a new fluorinated macrolide (P-0501A) and other erythromycins on drug metabolizing enzymes in rat liver.
Topics: Administration, Oral; Aminopyrine N-Demethylase; Animals; Body Weight; Cytochrome b Group; Cytochrome P-450 Enzyme System; Cytochromes b5; Drug Interactions; Enzyme Induction; Erythromycin; Erythromycin Estolate; Glutathione; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Organ Size; Pentobarbital; Rats; Sleep | 1986 |
Separation of folates from antibiotics using triethylamino cellulose.
Topics: Ampicillin; Anti-Bacterial Agents; Biological Assay; Cellulose; Cephaloridine; Chromatography, Thin Layer; Cloxacillin; Erythromycin; Evaluation Studies as Topic; Folic Acid; Gentamicins; Humans; Lacticaseibacillus casei; Lincomycin; Methaqualone; Methods; Nitrazepam; Oxytetracycline; Penicillin G; Pentobarbital; Promazine; Promethazine; Tetracycline | 1974 |